Meningitis therapeutics Flashcards

1
Q

3 membranes of meninges

A

dura mater
arachnoid
pia mater

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

meningitis location

A

subarachnoid space, between arachnoid and pia mater

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

meningitis pathophysiology sequence

A
  • nasopharyngeal colonization
  • bacterial release of proteases to degrade IgA
  • adhere to mucosa
  • polysaccharide capsule withstands neutrophil phagocytosis
  • capsule typically activates alternate complement pathway, when this fails meningitis occurs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

patients with increased risk of meningitis

A
  • immune suppressed
  • sickle cell
  • dysfunctional spleen or asplenia
  • immunoglobulin or complement deficiencies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

physical results of meningitis

A
  • cerebral edema
  • increased intracranial pressure
  • decreased cerebral perfusion with ischemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

neurologic complications of meningitis are the result of

A

host’s inflammatory pathways attempting to kill the bacteria

  • bacterial cell wall components released
  • cytokines, TNF, IL
  • platelet activating factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

bacteria that can cause meningitis

A

in order:

  • s.pneumoniae (58%)
  • s.agalactiae
  • N.meningitidis
  • H.influenzae
  • listeria monocytogenes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

bacteria that kills most rapidly

A

neisseria meningitidis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

role of the spleen

A
  • phagocytosis of old RBCs and antibody coated bacteria
  • stores platelets and monocytes
  • matures B cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

role of polysaccharide layer that envelopes bacteria

A
  • enhances virulence
  • prevents phagocytosis
  • enhances adhere to surfaces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bacteria with polysaccharide layer

A
  • H.influenzae
  • N.meningitidis
  • Klebsiella pneumonoiae
  • S.pneumoniae
  • S.agalactiae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

classic triad of symptoms for meningitis

A

fever
nuchal rigidity
mental status changes
headache also common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

kernig’s sign

A

patient lies supine, flex knee and hip of one leg to 90 degrees
pain = +test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

brudzinski’s sign

A

patient lies supine, lift pts neck off bed while having them try to touch chin to chest
involuntary flexion of hips and knees = +test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when it is ok to do lumbar puncture

A

no increase in intracranial pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

signs of increased ICP

A
  • severe headache
  • vomiting
  • decreased levels of consciousness
  • seizures
  • papilledema
  • coma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

in addition to increased ICP when do we also avoid lumbar puncture

A

pt has low platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

papilledema

A

optic nerve swelling that is observable with eye exam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

who should get a head CT prior to lumbar puncture

A
  • immunocompromised patients
  • hx of stroke
  • over 60
  • seizure in the last 7 days
  • papilledema
  • changing consciousness levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

labs for bacterial CSF infection

A
WBC 1000-5000
WBC diff - neutrophils dominate
protein 100-500
glucose <40
decreased CSF/serum glucose ratio
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

effects of dexamethasone

A
  • reduces intracerebral inflammation

- reduces antibiotic CNS penetration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

dexamethasone dosing

A

0.15 mg/kg q6h for 2-4 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

when to use dexamethasone in relation to antibiotics

A

10-20 minutes before the first abx dose or with the first dose and continue for 2-4 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

bacteria most common in < 1 mo. pts

A

e.coli
listeria
s.pneumoniae

25
Q

bacteria most common in 1-23 mo. pts

A

e. coli
h. influenzae
n. meningitidis
s. agalactiae
s. pneumoniae

26
Q

bacteria most common in 2-50 years

A

n. meningitidis

s. pneumoniae

27
Q

bacteria most common in >50 years

A

aerobic gnb
listeria
n.meningitidis
s.pneumoniae

28
Q

treatment for pts <1 mo

A

ampicillin + ceftriaxone or aminoglycoside

29
Q

treatment for pts 1-23 mos.

A

vanco+ceftriaxone

30
Q

treatment for pts 2-50 years

A

vanco+ceftriaxone

31
Q

treatment for patients >50 years

A

vanco+ceftriaxone+ampicilin

32
Q

empiric therapy for basilar skull fracture

A

vanco + ceftriaxone

33
Q

empiric therapy for pts with penetrating head trauma

A

vanco + cefepine
vanco + ceftazidime
vanco + meropenem

34
Q

empiric therapy for post-neurosurgery pts

A

vanco + cefepine
vanco + ceftazidime
vanco + meropenem

35
Q

empiric therapy for pts with CSF shunts

A

vanco + cefepine
vanco + ceftazidime
vanco + meropenem

36
Q

treatment for s.pneumoniae PCN s

A

Pen G or amp

37
Q

treatment for s.pneumoniae PCN r

A

vanco + ceftriaxone

38
Q

treatment for MSSA

A

nafcillin

39
Q

treatment for MRSA

A

vancomycin

40
Q

treatment for group b strep

A

pen G or amp+gent

41
Q

treatment for staph epidermidis

A

vancomycin

42
Q

treatment for listeria

A

pen g or amp+gent

43
Q

treatment for n.meningitidis PCN s

A

pen g or amp

44
Q

treatment for n.meningitidis PCN r

A

ceftriaxone

45
Q

treatment for enterobacteriaceae

A

ceftriaxone

46
Q

treatment for h.flu (beta-lac neg)

A

amp

47
Q

treatment for h.flu (beta.lac pos)

A

ceftriaxone

48
Q

treatment for p.aeruginosa

A

ceftazidime or cefepime +/- aminoglycoside

49
Q

treatment duration for s.pneumoniae

A

10-14 days

50
Q

treatment duration for s.aureus

A

14-21 days

51
Q

treatment duration for group b strep

A

14-21 days

52
Q

treatment duration for s.epidermidis

A

14-21 days

53
Q

treatment duration for listeria

A

21 days minimum

54
Q

treatment duration for n.meningitidis

A

7-10 days

55
Q

treatment duration for h.flu

A

7-10 days

56
Q

treatment duration for enterobacteriaceae

A

21 days

57
Q

treatment duration for p.aeruginosa

A

21 days

58
Q

prophylaxis for n.meningitidis

A

rifampin

59
Q

dexamethasone may have improved outcomes with which bacteria

A

s. pneumoniae

* consider DC’ing of different bacteria*